BFC Planning’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
BFC Planning's TXG Position: Q3 2026 in Review
BFC Planning increased its 10x Genomics (TXG) stake by 7.7% in Q3 2026, buying an estimated $1.7K and bringing the position to 404 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.
BFC Planning first reported a position in TXG in Q3 2024 and has held it in 9 quarters since. 396 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- BFC Planning held 404 shares of 10x Genomics worth $36.5K as of Q3 2026.
- BFC Planning bought 29 10x Genomics shares in Q3 2026, an estimated $1.7K.
- 10x Genomics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1716 holding.
- BFC Planning first reported a position in 10x Genomics in Q3 2024 and has held it in 9 quarters since.
- 396 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.